Quviviq Is Now Available

Released: 06/03/2022  

Quviviq (Daridorexant) has recently been released and is approved by the FDA. Quviviq is a prescription medicine for adults who have trouble falling asleep or staying asleep (insomnia).  Quviviq is a federally controlled substance because it can be abused or lead to dependence.

Quviviq (Daridorexant) belongs to a group of medications called orexin receptor antagonists (ORAs). It is related to Belsomra (suvorexant) and Dayvigo (Lemborexant).

Quviviq is manufactured by Idorsia Pharmaceuticals and is available in 25mg and 50mg tablets.

If you have any questions or if we may assist you with your workers’ compensation pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com.

The post Quviviq Is Now Available appeared first on Carlisle Medical.